TG Therapeutics, Inc. (TGTX)
$53.34+0.74%Close
SELLBEAR · day 6
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $8.2B
- Beta
- 1.66
- P/E (TTM)
- 17.14
- Short % float
- 22.32%
- Days to cover
- 18.5
- SI change
- +0.1%
- 1W
- -0.52%
- 1M
- -2.40%
- vs SPY 1W
- -2.08%
- vs SPY 1M
- -4.16%
Industry peers
FMP comparable companies · ranked by market cap
- KRYSSELLKrystal Biotech, Inc.$9.5BBEARQ 46$322.28+0.84%
- ARWRSELLArrowhead Pharmaceuticals, Inc.$9.0BCRISISQ 12$64.19-1.20%
- PTGXSELLProtagonist Therapeutics, Inc.$9.0BBEARQ 32$140.06-0.72%
- KYMRSELLKymera Therapeutics, Inc.$8.8BBEARQ 25$107.39+0.88%
- PCVXBUYVaxcyte, Inc.$8.2BRECOVERYQ 25$56.48-2.90%
- ALKSSELLAlkermes plc$7.0BRECOVERYQ 6$41.75-3.23%
- IMVTSELLImmunovant, Inc.$6.9BCRISISQ 25$33.62-5.56%
- ACLXArcellx, Inc.$6.7B$115.07
- CRSPSELLCRISPR Therapeutics AG$5.3BCRISISQ 20$55.43-3.65%
- PTCTSELLPTC Therapeutics, Inc.$5.3BRECOVERYQ 18$63.46-1.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
